Stockreport

bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test

bioAffinity Technologies, Inc.  (BIAF) 
PDF Validating sample collection by deep suction has potential to accelerate and expand adoption of CyPath® Lung SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, I [Read more]